Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

被引:241
作者
Ständer, S
Schmelz, M
Metze, D
Luger, T
Rukwied, R
机构
[1] Univ Hosp Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Univ Hosp Munster, Ludwig Boltzmann Inst Cell Biol & Immunol Ski, D-48149 Munster, Germany
[3] Univ Heidelberg, Fac Clin Med Mannheim, Dept Anesthesiol & Intens Care Med, Heidelberg, Germany
关键词
cannabinoid receptors; cutaneous nerve fibers; nociception; itch; human skin;
D O I
10.1016/j.jdermsci.2005.01.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Cannabinoid receptors mediate the psychopharmacological action of marijuana and have been localized in the central and peripheral nervous system as well as on cells of the immune system. Objective: Up to now, two cannabinoid receptors (CB1 and CB2) have been cloned and recent studies on animal tissue gave evidence for the presence of cannabinoid receptors in the skin. Methods: In the present immunohistochemical investigation we determined the precise localization of CB1 and CB2 in sections of human skin and in one case of mastocytosis. Results: CB1 and CB2 immunoreactivity was observed in cutaneous nerve fiber bundles, mast cells, macrophages, epidermal keratinocytes, and the epithelial. cells of hair follicles, sebocytes and eccrine sweat glands. In epidermal keratinocytes, hair follicle and sebaceous glands, CB1 and CB2 were distributed in a complementary fashion. Double-immunostaining with an anti-CGRP antibody suggested the presence of cannabinoid receptors on small afferent peptidergic nerves. Conclusion: The abundant distribution of cannabinoid receptors on skin nerve fibers and mast cells provides implications for an anti-inflammatory, anti-nociceptive action of cannabinoid receptor agonists and suggests their putatively broad therapeutic potential. (c) 2005 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 188
页数:12
相关论文
共 75 条
[1]   Short-term effects of cannabinoids in patients with HIV-1 infection - A randomized, placebo-controlled clinical trial [J].
Abrams, DI ;
Hilton, JF ;
Leiser, RJ ;
Shade, SB ;
Elbeik, TA ;
Aweeka, FT ;
Benowitz, NL ;
Bredt, BM ;
Kosel, B ;
Aberg, JA ;
Deeks, SG ;
Mitchell, TF ;
Mulligan, K ;
Bacchetti, P ;
McCune, JM ;
Schambelan, M .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (04) :258-266
[2]  
Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209
[3]   Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons [J].
Ahluwalia, J ;
Urban, L ;
Capogna, M ;
Bevan, S ;
Nagy, I .
NEUROSCIENCE, 2000, 100 (04) :685-688
[4]  
Arévalo-Martin A, 2003, J NEUROSCI, V23, P2511
[5]  
Baker D, 2003, EXPERT OPIN INV DRUG, V12, P561
[6]  
Benito C, 2003, J NEUROSCI, V23, P11136
[7]   Inhibition of tumor angiogenesis by cannabinoids [J].
Blázquez, C ;
Casanova, ML ;
Planas, A ;
del Pulgar, TG ;
Villanueva, C ;
Fernández-Aceñero, MJ ;
Aragonés, J ;
Huffman, JW ;
Jorcano, JL ;
Guzmán, M .
FASEB JOURNAL, 2003, 17 (01) :529-+
[8]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[9]   Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry [J].
Bridges, D ;
Rice, ASC ;
Egertová, M ;
Elphick, MR ;
Winter, J ;
Michael, GJ .
NEUROSCIENCE, 2003, 119 (03) :803-812
[10]   The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain [J].
Bridges, D ;
Ahmad, K ;
Rice, ASC .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (04) :586-594